1 / 10

Deep vein thrombosis Pulmonary embolism

Venous Thromboembolism. Treatment. Deep vein thrombosis Pulmonary embolism. …All the same?. Acute DVT. Management. What is the goal of therapy?. Acute DVT. Therapeutic Goals/Options. Caval Filter. Anticoagulation. Thrombolytic Rx. Thrombectomy. No Rx. Reduce PE. X. X. X. X.

tudor
Télécharger la présentation

Deep vein thrombosis Pulmonary embolism

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Venous Thromboembolism Treatment • Deep vein thrombosis • Pulmonary embolism …All the same?

  2. Acute DVT Management What is the goal of therapy?

  3. Acute DVT Therapeutic Goals/Options Caval Filter Anticoagulation Thrombolytic Rx Thrombectomy No Rx Reduce PE X X X X Prevent Extension X X + Reduce Recurrence X X + Restore Patency X X Preserve Valve Function X X + Reduce CVI X X

  4. Isolated Calf DVT 51 patients randomized Rx Heparin x 5 days Heparin x 5 days Warfarin x 3 mos 29% recurrent VTE No recurrent VTE 19% proximal DVT 4% pulmonary emboli Langerstedt CI, et al. Lancet 1985.

  5. Deep Vein Thrombosis Treatment • Initial treatment • Importance of therapeutic levels • Compression • Ambulation • Long-term treatment • 5 patient categories

  6. Acute DVT Importance of Early Rx Recurrent VTE* PTT <1.5x (24 hrs.) 24.5% (15:1) PTT >1.5x 1.6% <0.001 * • most occur > 4 weeks • association with poor initial response not appreciated by attending MDs Hull, RD et al NEJM 1990

  7. Heparin/LMWH Bioavailability Heparin for Acute DVT Plasma Level After SQ - Volunteers Single Subcutaneous Injection Plasma Recovery LMWH 90% Unfractionated heparin (UFH) 20% Bratt G, et al. Thromb Rea 1986;42(5):613-620. Bara L, et al. Thromb Res. 1985;39(5):631-636.

  8. LMWH vs. UFH for Acute DVT A Meta-Analysis of 10 Studies (n=759) • Prospective • Adjusted dose unfractionated heparin • Fixed dose SQ LMWH • Objective outcome measures Symptomatic recurrent DVT Change in thrombus size Major bleeding Mortality Bratt G, et al. Thromb Rea 1986;42(5):613-620. Bara L, et al. Thromb Res. 1985;39(5):631-636.

  9. LMWH vs. UFH for Acute DVT A Meta-Analysis of 10 Studies (n=759) Risk Reduction UFH LMWH P-value Venographic Change 6.5% 3.1% 53% <0.01 52% 63% - Improved 12% 6% <0.001 Worse Major Bleed 2.8% 0.8% 68% <0.005 Mortality 7.1% 3.9% 47% <0.04 Lensing AWA, et al Arch Intern Med 1995

  10. Deep Vein Thrombosis Initial Treatment: Compression & Ambulation • Proximal DVT- 53 patients • LMWH...then randomize: • Bed rest • Ambulation + 35 mm Hg stocking • Ambulation + 50 mm Hg compression bandage • Activity measured - pedometer • Venous duplex days 0 & 9 1. Blattler W., et al Int’l Angiol. 2003; 32: 861-9 2. Partsch H. et al J Vasc Surg 2000; 32: 861-9

More Related